
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
Haider Ghazanfar, Nismat Javed, Abeer Qasim, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1214-1214
Open Access | Times Cited: 12
Haider Ghazanfar, Nismat Javed, Abeer Qasim, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1214-1214
Open Access | Times Cited: 12
Showing 12 citing articles:
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access
Effects of experimental hepatic steatosis on apelin and various biochemical parameters in male white rabbits.
Rana Suhail Al-Juwary, Muntaha M. Al-Kattan
PubMed (2025) Vol. 15, Iss. 1, pp. 211-221
Closed Access
Rana Suhail Al-Juwary, Muntaha M. Al-Kattan
PubMed (2025) Vol. 15, Iss. 1, pp. 211-221
Closed Access
Masld-Related Hepatocarcinoma: Special Features And Challenges
Carmen Yagüe-Caballero, Diego Casas Deza, Silvia Espina, et al.
(2024)
Open Access | Times Cited: 1
Carmen Yagüe-Caballero, Diego Casas Deza, Silvia Espina, et al.
(2024)
Open Access | Times Cited: 1
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol
Anja M. Fischer, Nazim Lechea, Harvey O. Coxson
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 226-238
Open Access | Times Cited: 1
Anja M. Fischer, Nazim Lechea, Harvey O. Coxson
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 226-238
Open Access | Times Cited: 1
Evaluation of Nomenclature of Fatty Liver Disease in Association with Hepatocellular Carcinoma: A 15.5-Year Cohort Study in Korea
Tung Hoang, Jeonghee Lee, Bo Hyun Kim, et al.
(2024)
Closed Access | Times Cited: 1
Tung Hoang, Jeonghee Lee, Bo Hyun Kim, et al.
(2024)
Closed Access | Times Cited: 1
Exploring Fibrosis Pathophysiology in Lean and Obese Metabolic-Associated Fatty Liver Disease: An In-Depth Comparison
Milena Vesković, M Pejović, Nikola Šutulović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7405-7405
Open Access | Times Cited: 1
Milena Vesković, M Pejović, Nikola Šutulović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7405-7405
Open Access | Times Cited: 1
The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet
Ramasamy Selvarani, Hai Thanh Nguyen, N. Pazhanivel, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Ramasamy Selvarani, Hai Thanh Nguyen, N. Pazhanivel, et al.
GeroScience (2024)
Open Access | Times Cited: 1
Synergistic Beneficial Effects of Flaxseed (Linum usitatissimum L.) Oil and Olive (Olea europaea L.) Oil Against Metabolic Dysfunction Associated Fatty Liver and Its Complications
Sana Noreen, Bushra Hashmi, Tabussam Tufail, et al.
Food Science & Nutrition (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Sana Noreen, Bushra Hashmi, Tabussam Tufail, et al.
Food Science & Nutrition (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
ВПЛИВ ЛІПІДНОГО ТА ВУГЛЕВОДНОГО ОБМІНУ НА СТРУКТУРНІ ЗМІНИ ОКА У ПАЦІЄНТІВ РІЗНОЇ СТАТІ
М. В. Турчин, І. М. Кліщ
Medical and Clinical Chemistry (2024), Iss. 2, pp. 12-16
Open Access
М. В. Турчин, І. М. Кліщ
Medical and Clinical Chemistry (2024), Iss. 2, pp. 12-16
Open Access
Management of non-alcoholic fatty liver disease-associated hepatocellular carcinoma
Peijun Xu, M. Liu, Miao Liu, et al.
BioScience Trends (2024)
Open Access
Peijun Xu, M. Liu, Miao Liu, et al.
BioScience Trends (2024)
Open Access
Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation
Lingling Wang, Yuming Lu, Yihan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 47, pp. 5055-5069
Closed Access
Lingling Wang, Yuming Lu, Yihan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 47, pp. 5055-5069
Closed Access
MASHing up molecular imaging and biomarkers for improved diagnosis of metabolic dysfunction-associated steatotic liver disease
Sharmila Fagoonee, Riccardo Panella
Minerva Biotechnology and Biomolecular Research (2024) Vol. 36, Iss. 4
Closed Access
Sharmila Fagoonee, Riccardo Panella
Minerva Biotechnology and Biomolecular Research (2024) Vol. 36, Iss. 4
Closed Access